Highlights

  • First Victorian Empax clinic set to commence patient treatments in Q2 CY2026
  • 31 therapists and six psychiatrists contracted and trained to ensure operational readiness
  • Dual reimbursement pathways via Medibank Private and DVA support early revenue visibility

Emyria Limited (ASX:EMD) is progressing toward the launch of its first Victorian Empax clinic, with patient treatments on schedule for Q2 CY2026. The clinic forms a key part of Emyria’s national rollout strategy, increasing capacity to deliver reimbursable, evidence-based mental health treatments. The company has trained 31 therapists and six psychiatrists, ensuring workforce readiness and scalability. Operational milestones, including agreements with Avive Health and secured medication supply, reduce execution risk. Dual reimbursement pathways from Medibank Private and the Department of Veterans' Affairs further support early patient uptake and revenue visibility.

Operational and Clinical Readiness

Emyria has finalized agreements with Avive Health, allowing minor clinic fit-outs and integration of clinical governance processes. Workforce preparation includes 31 therapists and four trained psychiatrists, with two more scheduled in Q2 CY2026, ensuring sufficient capacity for patient throughput. Medication supply and pharmacy agreements are in place, mitigating execution risks. These steps establish a strong foundation for the clinic’s operational launch and support a smooth ramp-up phase post-opening.

Revenue Pathways and Strategic Expansion

Revenue visibility is strengthened through dual reimbursement channels. Medibank Private funds eligible patients for Treatment-Resistant Depression and PTSD treatments at the Mornington Peninsula facility, while the Department of Veterans’ Affairs provides funding for veterans accessing medication-assisted therapy. These pathways underpin early utilisation rates, reducing reliance on self-funded patients. The Victorian clinic expands Emyria’s treatment footprint, increases capacity, and positions the company to scale the Empax model nationally. Executive Chairman Greg Hutchinson emphasized the clinic’s potential to drive growth and access to evidence-based mental health care.

FAQs

  1. When will Emyria’s Victorian Empax clinic start treatments?

Patient treatments are on track to commence in Q2 CY2026.

  1. How many clinicians are ready for the clinic launch?

The clinic has 31 trained therapists and six psychiatrists, with two more psychiatrists scheduled in Q2 CY2026.

  1. How is revenue supported for the new clinic?

Revenue is backed by dual reimbursement pathways through Medibank Private and the Department of Veterans' Affairs